Plaquenil maculopathy is a rare, but visually debilitating complication of using hydroxychloroquine medication. This course details utilizing special testing including Visual Fields and OCT for diagnosis. The 2011 and 2016 American Academy of Ophthalmology management recommendations including treatment and follow-up will be discussed, including what height, weight, and dosage constitutes high risk. New information about risk modification will help the optometrist manage patients on Plaquenil.
- 1. Educate about side effects of plaquenil maculopathy.
- 2. Discuss testing for plaquenil maculopathy. OCT will be discussed in depth including using the 'flying saucer sign' to discover early toxic complication.
- 3. Clear understanding of frequency of follow up and treatment strategies through case discussion.